|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 295.52 USD | -1.55% |
|
+0.35% | -16.25% |
| 06-30 | United Therapeutics' Tyvaso to Benefit from Q2 Seasonality, UBS Says | MT |
| 06-30 | UBS Adjusts Price Target on United Therapeutics to $385 From $410, Maintains Buy Rating | MT |
Trading Ideas
Search
24-02-15 |  | |
21-03-01 | | |
20-12-15 | | |
16-02-05 | | |
13-05-02 | |
No results for this search
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition